Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded encouraging insights into new therapeutic approaches. Current research centers on addressing the underlying pathophysiology of MSA. One avenue under investigation involves pharmacological interventions to influence the